Bowel (colorectal) cancer, Rectal cancer
Results
Phase 2
This trial looked at durvalumab and radiotherapy for cancer of the back passage (rectal cancer). It was for people whose cancer had grown into the bowel wall, but had not spread to another part of the body.
The trial was supported by Cancer Research UK. People could join the trial between 2021 and 2023. The team presented the results at a conference in 2025.
Recruitment start: 15 January 2021
Recruitment end: 24 May 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mr Campbell Roxburgh
AstraZeneca
Cancer Research UK
University of Glasgow
NHS Greater Glasgow and Clyde
Last reviewed: 14 May 2026
CRUK internal database number: 17187
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
